| HOME >> BIOLOGY >> TECHNOLOGY |
Toronto Stock Exchange Symbol: MS
EDMONTON, AB, May 3 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), today announced its updated corporate strategy. The Company's new strategy will encompass becoming a full service provider in the healthcare industry, whereby BioMS will directly invest in and advise companies on strategy, financing, mergers & acquisitions (M&A), licensing transactions and undertake technology development. The Company also announced it has hired Mr. Nitin Kaushal, a leading healthcare investment banker, as Executive Vice President and Managing Director.
"There is a significant opportunity in today's market place - great healthcare technologies reside in companies that are otherwise under-funded and under-resourced, particularly in Canada and Europe," said Kevin Giese, President and CEO of BioMS Medical. "Our strategy is to invest our financial and human capital into healthcare related opportunities to create value for our stakeholders and we believe that our new structure and focus will maximize our current resources."
BioMS Medical also announced it intends to change its name to Medwell Capital Corp. subject to approval by the Toronto Stock Exchange and shareholders at the annual general meeting to be held on June 25, 2010.
Appointment of Mr. Nitin Kaushal
--------------------------------
Mr. Kaushal will be responsible for the implementation of the Company's strategy to become a full service provider to the healthcare industry. Mr. Kaushal brings more than 25 years of financial and investment experience to BioMS, including expertise in the areas of
'/>"/>
| SOURCE BioMS Medical Corp. Copyright©2010 PR Newswire. All rights reserved |